MBP-1 is efficiently encoded by an alternative transcript of the ENO1 gene but post-translationally regulated by proteasome-dependent protein turnover

FEBS Journal

Volumn 277, Issue 20, 2010, Pages 4308-4321

  Lung, Jrhau ^a   Liu, Ko Jiunn ^a   Chang, Jang Yang ^a   Leu, Sy Jye ^b   Shih, Neng Yao ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

enolase; alternative transcription initiation; c myc promoter binding protein 1; protein stability; ubiquitination

Indexed keywords

ALPHA ENOLASE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; COMPLEMENTARY DNA; LUCIFERASE; MESSENGER RNA; MYC PROMOTOR BINDING PROTEIN 1; MYC PROTEIN; PROTEASOME INHIBITOR; UNCLASSIFIED DRUG; DENND4A PROTEIN, HUMAN; DNA BINDING PROTEIN; ENO1 PROTEIN, HUMAN; ENOLASE; PROTEASOME; PROTEIN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CELL; CANCER GENE THERAPY; CELL ASSAY; CELL FRACTIONATION; CONTROLLED STUDY; DNA TEMPLATE; GENE EXPRESSION; GENETIC TRANSCRIPTION AND TRANSLATION; HUMAN; HUMAN CELL; HYPOXIA; INTRON; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; ANOXIA; BIOSYNTHESIS; BRONCHUS; CELL CULTURE; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANOXIA; BRONCHI; CELLS, CULTURED; DNA-BINDING PROTEINS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTRONS; PHOSPHOPYRUVATE HYDRATASE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 77957282695     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07819.x     Document Type: Article

References (25)

1. Ray R Miller DM (1991) Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol 11, 2154 2161. (Pubitemid 21895587)
2. Ray RB, Steele R, Seftor E Hendrix M (1995) Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res 55, 3747 3751.
3. Ejeskar K, Krona C, Caren H, Zaibak F, Li L, Martinsson T Ioannou PA (2005) Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death. BMC Cancer 5, 161. (Pubitemid 43013362)
4. Ghosh AK, Steele R, Ryerse J Ray RB (2006) Tumor-suppressive effects of MBP-1 in non-small cell lung cancer cells. Cancer Res 66, 11907 11912. (Pubitemid 46094203)
5. Ghosh AK, Steele R Ray RB (2005) c-myc Promoter-binding protein 1 (MBP-1) regulates prostate cancer cell growth by inhibiting MAPK pathway. J Biol Chem 280, 14325 14330. (Pubitemid 40517336)
6. Perconti G, Ferro A, Amato F, Rubino P, Randazzo D, Wolff T, Feo S Giallongo A (2007) The kelch protein NS1-BP interacts with alpha-enolaseMBP-1 and is involved in c-Myc gene transcriptional control. Biochim Biophys Acta 1773, 1774 1785. (Pubitemid 350191977)
7. Sedoris KC, Thomas SD Miller DM (2007) c-myc promoter binding protein regulates the cellular response to an altered glucose concentration. Biochemistry 46, 8659 8668.
8. Giallongo A, Feo S, Moore R, Croce CM Showe LC (1986) Molecular cloning and nucleotide sequence of a full-length cDNA for human alpha enolase. Proc Natl Acad Sci USA 83, 6741 6745. (Pubitemid 16002309)
9. Onyango P, Lubyova B, Gardellin P, Kurzbauer R Weith A (1998) Molecular cloning and expression analysis of five novel genes in chromosome 1p36. Genomics 50, 187 198. (Pubitemid 28303512)
10. White RA, Adkison LR, Dowler LL Ray RB (1997) Chromosomal localization of the human gene encoding c-myc promoter-binding protein (MPB1) to chromosome 1p35-pter. Genomics 39, 406 408. (Pubitemid 27078709)
11. Ghosh AK, Steele R Ray RB (1999) Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation. Mol Cell Biol 19, 2880 2886. (Pubitemid 29144532)
12. Feo S, Arcuri D, Piddini E, Passantino R Giallongo A (2000) ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett 473, 47 52. (Pubitemid 30235183)
13. Subramanian A Miller DM (2000) Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem 275, 5958 5965. (Pubitemid 30115245)
14. Shaw RJ (2006) Glucose metabolism and cancer. Curr Opin Cell Biol 18, 598 608.
15. Jang BC, Munoz-Najar U, Paik JH, Claffey K, Yoshida M Hla T (2003) Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression. J Biol Chem 278, 2773 2776. (Pubitemid 36801177)
16. Ray RB Steele R (1997) Separate domains of MBP-1 involved in c-myc promoter binding and growth suppressive activity. Gene 186, 175 180. (Pubitemid 27107682)
17. Vogel HJ Vogel RH (1967) Regulation of protein synthesis. Annu Rev Biochem 36, 519 538.
18. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, Semple CA, Taylor MS, Engstrom PG, Frith MC et al. (2006) Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 38, 626 635. (Pubitemid 43927303)
19. Minato Y, Tashiro E, Kanai M, Nihei Y, Kodama Y Imoto M (2007) Transcriptional regulation of a new variant of human platelet-derived growth factor receptor alpha transcript by E2F-1. Gene 403, 89 97. (Pubitemid 47488717)
20. Chang GC, Liu KJ, Hsieh CL, Hu TS, Charoenfuprasert S, Liu HK, Luh KT, Hsu LH, Wu CW, Ting CC et al. (2006) Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clin Cancer Res 12, 5746 5754. (Pubitemid 44629605)
21. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43 54. (Pubitemid 32972036)
22. Maranchie JK, Vasselli JR, Riss J, Bonifacino JS, Linehan WM Klausner RD (2002) The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell 1, 247 255. (Pubitemid 41039149)
23. Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, Wu R Wu CW (1997) Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 17, 353 360. (Pubitemid 127500840)
24. Sadeh R, Breitschopf K, Bercovich B, Zoabi M, Kravtsova-Ivantsiv Y, Kornitzer D, Schwartz A Ciechanover A (2008) The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system. Proc Natl Acad Sci USA 105, 15690 15695.
25. Yuan A, Yu CJ, Shun CT, Luh KT, Kuo SH, Lee YC Yang PC (2005) Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients. Int J Cancer 115, 545 555. (Pubitemid 40656711)